Q3 2024 Earnings Call Transcript November 11, 2024 Operator: Thank you for standing by. My name is John, and I’ll be your conference operator today. At this time, I would like to welcome everyone to ...

Assertio Holdings (ASRT)于2024年11月8日讨论了其第三季度业绩,由首席执行官Brendan O'Grady和首席财务官Ajay Patel主持电话会议。公司报告本季度总产品销售额略有下降,为2870万美元,低于上一季度的3070万美元,主要是由于INDOCIN销售额下降。尽管整体销售有所下滑,但Assertio的旗舰产品ROLVEDON仍保持了1500万美元的稳定销售。

Third Quarter Total Net Product Sales of $28.7 MillionRolvedon Net Product Sales of $15.0 Million Cash and Short-Term Investments of $88.6 ...

Third Quarter Total Net Product Sales of $28.7 Million Rolvedon Net Product Sales of $15.0 Million Cash and Short-Term Investments of $88.6 Million LAKE FOREST, Ill., Nov. 11, 2024 (GLOBE NEWSWIRE) ...

In the U.S., six non-steroidal anti-inflammatory drugs (NSAIDs) are most commonly used to manage pain and inflammation. While this drug class is widely relied upon, it is also associated with ...